PCI Pharma Services To Acquire Pharmaceutical Packaging Company
By

By
PCI Pharma Services, a Philadelphia, Pennsylvania-based pharmaceutical contract service provider, has acquired PPP, a Melbourne, Victoria, Australia-headquartered provider of clinical trial manufacturing, packaging, storage, and distribution services. PPP has a…

UK Grants Cobra Biologics, Symbiosis $2.5 Million for Viral-Vector Mfg
By

By
Cobra Biologics, a Keele, UK-headquartered contract development and manufacturing organization for biologics and pharmaceuticals, and Symbiosis Pharmaceutical Services, a Stirling, Scotland-headquartered contract manufacturing organization, have been awarded a 16-month collaborative…

Constantia Flexibles Invests in Production Capacity in India
By

By
Constantia Flexibles, a Vienna, Austria-headquartered packaging company, is investing INR 100 crore ($15 million) to expand production capacity at its Indian subsidiary, Parikh Packaging, in Ahmedabad, Gujarat, India. The company…

Cryoport, TiGenix Partner for Logistics for Stem-Cell Therapies
By

By
Cryoport, an Irvine, California-headquartered cryogenic logistics company, has agreed to support TiGenix, a ‎Leuven, Belgium-headquartered biopharmaceutical company developing stem-cell therapies, as it conducts a Phase Ib/IIa clinical study to evaluate…

Lonza, Denali Therapeutics in Biologics Pact
By

By
Lonza and Denali Therapeutics, a San Francisco, California-headquartered biopharmaceutical company developing drugs for treating neurodegenerative diseases, have partnered for development and manufacturing for Denali’s biologic pipeline products for neurodegenerative diseases.…

Indena Opens New Kilolab for Highly Potent APIs; Plans Further Expansions
By

By
Indena, a Milan, Italy-headquartered contract manufacturing organization for the identification, development, and production of active pharmaceutical ingredients (APIs) derived from plants, has opened a new kilolab for highly potent active…

GSK, J&J, and Pfizer Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from GlaxoSmithKline, Johnson & Johnson, and Pfizer. Editor’s Note: This article was updated on…

Novartis, Momenta, Gilead Sciences, J&J Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Novartis, Momenta Pharmaceuticals, Gilead Sciences, and Johnson & Johnson. Editor’s Note: This article was updated on…

Roivant Partners for Diabetes Drug in up to $650-Million Deal
By

By
Roivant Sciences, a Basel, Switzerland globally-headquartered biopharmaceutical company, and Poxel SA, a Lyon, France-based biopharmaceutical company developing treatments for metabolic disorders, have signed a development and license agreement for imeglimin,…

Takeda, Fujifilm in Pact for Regenerative Therapies
By

By
Takeda Pharmaceutical and Fujifilm have partnered to develop regenerative medicine therapies using cardiomyocytes derived from induced pluripotent stem cells (iPSC) for treating heart failure. Takeda and Fujifilm signed a contract…